73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Outpatient stem cell transplants result in less hospitalization time for multiple myeloma patients, study finds

Outpatient stem cell transplants result in less hospitalization time for multiple myeloma patients, study finds

by Leslie Cantu,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainMost multiple myeloma patients undergoing stem cell transplants of their own cells can safely be treated in

Outpatient stem cell transplants result in less hospitalization time for multiple myeloma patients, study finds

by Leslie Cantu,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainMost multiple myeloma patients undergoing stem cell transplants of their own cells can safely be treated in
Ewing sarcoma tumors can be split into two groups for targeted care

Ewing sarcoma tumors can be split into two groups for targeted care

by Cincinnati Children's Hospital Medical CenterA. Bright field images of CCH1 and CCH2 cells B. CCH1 and CCH2 cells cells stained with antibody towards CD99 (green) and DAPI (blue) C. Wester

Ewing sarcoma tumors can be split into two groups for targeted care

by Cincinnati Children's Hospital Medical CenterA. Bright field images of CCH1 and CCH2 cells B. CCH1 and CCH2 cells cells stained with antibody towards CD99 (green) and DAPI (blue) C. Wester
New biomarker for early prediction of response to CAR-T cell therapy

New biomarker for early prediction of response to CAR-T cell therapy

by Medical University of ViennaCredit: AI-generated imageA MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequ

New biomarker for early prediction of response to CAR-T cell therapy

by Medical University of ViennaCredit: AI-generated imageA MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequ
Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be
Cancer patients diagnosed early are more likely to avoid chemotherapy

Cancer patients diagnosed early are more likely to avoid chemotherapy

by Cancer Research UKCredit: Cancer Research UKCancer patients are around five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if they are diagnose

Cancer patients diagnosed early are more likely to avoid chemotherapy

by Cancer Research UKCredit: Cancer Research UKCancer patients are around five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if they are diagnose
Immune targets for chemotherapy-resistant breast cancers identified

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-
In situ, invasive melanoma diagnoses decreased in 2020

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from
Study: Access to cannabis for cancer patients is not equitable

Study: Access to cannabis for cancer patients is not equitable

by Bert Gambini,University at BuffaloCredit: Pixabay/CC0 Public DomainThe same factors driving many health care disparities in the U.S. are also affecting who has access to cannabis for managing

Study: Access to cannabis for cancer patients is not equitable

by Bert Gambini,University at BuffaloCredit: Pixabay/CC0 Public DomainThe same factors driving many health care disparities in the U.S. are also affecting who has access to cannabis for managing
Study reveals pathways for aggressive prostate cancer subtype

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati
Zika virus could help combat brain cancer

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi
Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi
Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

by Agency for Science, Technology and Research (A*STAR), SingaporeA plot of all the different possible phenotypes of T cells before without (left) vs. with (right) immune checkpoint blockade immu

Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

by Agency for Science, Technology and Research (A*STAR), SingaporeA plot of all the different possible phenotypes of T cells before without (left) vs. with (right) immune checkpoint blockade immu